Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-11-018892
Filing Date
2011-03-31
Accepted
2011-03-31 14:41:07
Documents
12
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 v216857_6k.htm 6-K 4691808
2 GRAPHIC a-logo.jpg GRAPHIC 5341
3 GRAPHIC c2-logo.jpg GRAPHIC 6108
4 GRAPHIC c2-pg01.jpg GRAPHIC 160531
5 GRAPHIC c2-pg10.jpg GRAPHIC 43959
6 GRAPHIC c2-pg24.jpg GRAPHIC 38733
7 GRAPHIC c2-pg30.jpg GRAPHIC 24925
8 GRAPHIC c2-pg33a.jpg GRAPHIC 44839
9 GRAPHIC c2-pg33b.jpg GRAPHIC 39213
10 GRAPHIC c2-pg34.jpg GRAPHIC 47866
11 GRAPHIC chart.jpg GRAPHIC 41345
12 GRAPHIC sixk-logo.jpg GRAPHIC 8835
  Complete submission text file 0001144204-11-018892.txt   5330450
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 11725431
SIC: 2834 Pharmaceutical Preparations